<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607190</url>
  </required_header>
  <id_info>
    <org_study_id>4C-2012-02</org_study_id>
    <nct_id>NCT01607190</nct_id>
  </id_info>
  <brief_title>Biomarkers of Diabetic Retinopathy Progression</brief_title>
  <acronym>C-Tracer</acronym>
  <official_title>Biomarkers of Diabetic Retinopathy Progression.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association for Innovation and Biomedical Research on Light and Image</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association for Innovation and Biomedical Research on Light and Image</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate a predictive model of diabetic retinopathy
      progression in patients with diabetes mellitus type 2 patients to clinically significant
      macular edema (CSME) needing treatment either photocoagulation or intravitreal injections
      (ITV) using non-invasive techniques.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CSME needing treatment either photocoagulation or ITV.</measure>
    <time_frame>Months 0, 6, 12 and 24.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity.</measure>
    <time_frame>Months 0, 6, 12 and 24.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vision loss of at least 2 lines documented in ETDRS charts</measure>
    <time_frame>Months 0, 6, 12 and 24.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>Months 0, 6, 12 and 24.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microaneurysm(MA) activity (number of MA, MA formation and MA disappearance rates and MA turnover)</measure>
    <time_frame>Months 0, 6, 12 and 24.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Mild Nonproliferative Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>Patients with diabetic retinopathy.</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  Age over 35 years-old

          -  Non-proliferative diabetic retinopathy (Levels 20 to 35, according the ETDRS criteria)

          -  Best Corrected Visual Acuity &gt; 20/25 on the ETDRS chart

          -  Informed Consent

        Exclusion Criteria:

          -  Previous laser therapy

          -  Other retinal vascular disease

          -  Glaucoma

          -  Recent intraocular surgery (in the last 6 months)

          -  Inadequate ocular media and/ or pupil dilatation that do not permit good quality
             fundus photography (e.g. cataract)

          -  HbA1C &gt; 11 % at the Screening

          -  Subject that has a condition or that is in a situation which may put him/her at
             significant risk, may confound the study results or may interfere significantly with
             his/ her participation in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jos√© Cunha-Vaz, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Association for Innovation and Biomedical Research on Light and Image</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LV Prasad Eye Institute</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500 034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AIBILI- Association for Biomedical Research and Inovation on Light and Image.</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-548</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
    <country>Portugal</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 2 diabetes mellitus</keyword>
  <keyword>nonproliferative diabetic retinopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

